Covered recipient · General Payments record
DAVID H CRUZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,792.34
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.67 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $99.30 | 4 |
| GlaxoSmithKline, LLC. | $43.79 | 2 |
| Exact Sciences Corporation | $41.00 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.31 | 1 |
| Amgen Inc. | $16.28 | 1 |
| Novo Nordisk AS | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.28 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231473 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.31 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086118132 | CMS |
| Exact Sciences Corporation | $24.28 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114624629 | CMS |
| Exact Sciences Corporation | $16.72 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114624634 | CMS |
| GlaxoSmithKline, LLC. | $24.59 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116138482 | CMS |
| GlaxoSmithKline, LLC. | $19.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116030613 | CMS |
| Lilly USA, LLC | $26.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136139851 | CMS |
| Lilly USA, LLC | $14.73 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136155621 | CMS |
| Lilly USA, LLC | $28.48 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136155623 | CMS |
| Lilly USA, LLC | $30.09 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136155619 | CMS |
| Novo Nordisk Inc | $13.99 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096698407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.